Tc-99m-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection
2002-01-01 Gratz, S; Rennen, Hjjm; Boerman, Oc; Oyen, W; Mast, P; Behr, Tm; Corstens, Fhm
Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting
2002-01-01 Janssen, M; Oyen, W; Massuger, Lfag; Frielink, C; Dijkgraaf, I; Edwards, Ds; Radjopadhye, M; Corstens, Fhm; Boerman, Oc
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state
2003-01-01 de Vries, Ijm; Krooshoop, Djeb; Scharenborg, Nm; Lesterhuis, Wj; Diepstra, Jhs; van Muijen, Gnp; Strijk, Sp; Ruers, Tj; Boerman, Oc; Oyen, W; Adema, Gj; Punt, Cja; Figdor, Cg
PET-CT: a matter of opinion?
2003-01-01 Jager, Pl; Slart, Rhja; Corstens, F; Oyen, W; Hoekstra, O; Teule, J
Tumor targeting with alpha(v)beta(3) integrin binding peptides
2003-01-01 Boerman, Oc; Oyen, W; Frielink, C; Dijkgraaf, I; Harris, Td; Edwards, Ds; Corstens, Fhm
Small peritoneal metastases of colorectal origin: An excellent target for radioimmunotherapy.
2003-01-01 Koppe, Mj; Soede, Ac; Oyen, W; Bleichrodt, Rp; Goldenberg, Dm; Boerman, Oc
A DOTA-conjugated peptidomimetic alpha(v)beta(3) integrin-binding agent for targeting tumors.
2003-01-01 Boerman, Oc; Frielink, C; Dijkgraaf, I; Oyen, W; Harris, Td; Edwards, Ds; Kuesters, B; Leenders, Wp; Corstens, Fh
Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis
2003-01-01 Brouwers, Fm; Oyen, W; Boerman, Oc; Barrett, Ja; Verheugt, Fwa; Corstens, Fhm; Van der Meer, Jwm
Kinetics of Tc-99m-Labeled interleukin-8 in experimental inflammation and infection
2003-01-01 Rennen, Hjjm; Boerman, Oc; Oyen, W; Corstens, Fhm
Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with I-131 or In-111: An intrapatient comparison
2003-01-01 Brouwers, Ah; Buijs, Wcam; Oosterwijk, E; Boerman, Oc; Mala, C; De Mulder, Phm; Corstens, Fhm; Mulders, Pfa; Oyen, W
Dosimetric analysis of radioimmunotherapy with Re-186-labeled bivatuzumab in patients with head and neck cancer
2003-01-01 Postema, Ej; Borjesson, Pke; Buijs, Wcam; Roos, Jc; Marres, Ham; Boerman, Oc; de Bree, R; Lang, M; Munzert, G; van Dongen, Gams; Oyen, W
Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin
2003-01-01 Koppe, E; Soede, Ac; Pels, W; Oyen, W; Goldenberg, Dm; Bleichrodt, Rp; Boerman, Oc
FDG-PET scanning in the diagnosis of gastrointestinal cancers
2004-01-01 van Kouwen, Mca; Oyen, W; Nagengast, Fm; Jansen, Jbmj; Drenth, Jph
PET/CT: Panacea, redundancy, or something in between?
2004-01-01 Vogel, Wv; Oyen, W; Barentsz, Jo; Kaanders, Jham; Corstens, Fhm
Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation
2014-01-01 Dell'Era, A; Iannuzzi, F; Fabris, Fm; Fontana, P; Reati, R; Grillo, P; Aghemo, A; de Franchis, R; Primignani, M
F-18-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients
2007-01-01 Troost, Egc; Vogel, Wv; Merkx, Maw; Slootweg, Pj; Marres, Ham; Peeters, Wjm; Bussink, J; van der Kogel, Aj; Oyen, W; Kaanders, Jham
Determining the optimal tumor volume cut-off for prediction of biochemical recurrence after radical prostatectomy in high-risk prostate cancer patients
2012-01-01 Castiglione, F; Albersen, M; Russo, A; Abdollah, F; Passoni, N; Gallina, A; Suardi, N; Cestari, A; Guazzoni, G; Rigatti, P; Briganti, A
Radionuclide therapy of cancer with radiolabeled antibodies
2007-01-01 Boerman, Oc; Koppe, Mj; Postema, Ej; Corstens, Fh; Oyen, W
Gender differences in Parkinson's disease
2007-01-01 Haaxma, Ca; Bloem, Br; Borm, Gf; Oyen, W; Leenders, Kl; Eshuis, S; Booij, J; Dluzen, De; Horstink, Mw
Development and application of peptide-based radiopharmaccuticals
2007-01-01 Dijkgraaf, I; Boerman, Oc; Oyen, W; Corstens, Fhm; Gotthardt, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Tc-99m-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection | 1-gen-2002 | Gratz, S; Rennen, Hjjm; Boerman, Oc; Oyen, W; Mast, P; Behr, Tm; Corstens, Fhm | |
| Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting | 1-gen-2002 | Janssen, M; Oyen, W; Massuger, Lfag; Frielink, C; Dijkgraaf, I; Edwards, Ds; Radjopadhye, M; Corstens, Fhm; Boerman, Oc | |
| Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state | 1-gen-2003 | de Vries, Ijm; Krooshoop, Djeb; Scharenborg, Nm; Lesterhuis, Wj; Diepstra, Jhs; van Muijen, Gnp; Strijk, Sp; Ruers, Tj; Boerman, Oc; Oyen, W; Adema, Gj; Punt, Cja; Figdor, Cg | |
| PET-CT: a matter of opinion? | 1-gen-2003 | Jager, Pl; Slart, Rhja; Corstens, F; Oyen, W; Hoekstra, O; Teule, J | |
| Tumor targeting with alpha(v)beta(3) integrin binding peptides | 1-gen-2003 | Boerman, Oc; Oyen, W; Frielink, C; Dijkgraaf, I; Harris, Td; Edwards, Ds; Corstens, Fhm | |
| Small peritoneal metastases of colorectal origin: An excellent target for radioimmunotherapy. | 1-gen-2003 | Koppe, Mj; Soede, Ac; Oyen, W; Bleichrodt, Rp; Goldenberg, Dm; Boerman, Oc | |
| A DOTA-conjugated peptidomimetic alpha(v)beta(3) integrin-binding agent for targeting tumors. | 1-gen-2003 | Boerman, Oc; Frielink, C; Dijkgraaf, I; Oyen, W; Harris, Td; Edwards, Ds; Kuesters, B; Leenders, Wp; Corstens, Fh | |
| Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis | 1-gen-2003 | Brouwers, Fm; Oyen, W; Boerman, Oc; Barrett, Ja; Verheugt, Fwa; Corstens, Fhm; Van der Meer, Jwm | |
| Kinetics of Tc-99m-Labeled interleukin-8 in experimental inflammation and infection | 1-gen-2003 | Rennen, Hjjm; Boerman, Oc; Oyen, W; Corstens, Fhm | |
| Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with I-131 or In-111: An intrapatient comparison | 1-gen-2003 | Brouwers, Ah; Buijs, Wcam; Oosterwijk, E; Boerman, Oc; Mala, C; De Mulder, Phm; Corstens, Fhm; Mulders, Pfa; Oyen, W | |
| Dosimetric analysis of radioimmunotherapy with Re-186-labeled bivatuzumab in patients with head and neck cancer | 1-gen-2003 | Postema, Ej; Borjesson, Pke; Buijs, Wcam; Roos, Jc; Marres, Ham; Boerman, Oc; de Bree, R; Lang, M; Munzert, G; van Dongen, Gams; Oyen, W | |
| Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin | 1-gen-2003 | Koppe, E; Soede, Ac; Pels, W; Oyen, W; Goldenberg, Dm; Bleichrodt, Rp; Boerman, Oc | |
| FDG-PET scanning in the diagnosis of gastrointestinal cancers | 1-gen-2004 | van Kouwen, Mca; Oyen, W; Nagengast, Fm; Jansen, Jbmj; Drenth, Jph | |
| PET/CT: Panacea, redundancy, or something in between? | 1-gen-2004 | Vogel, Wv; Oyen, W; Barentsz, Jo; Kaanders, Jham; Corstens, Fhm | |
| Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation | 1-gen-2014 | Dell'Era, A; Iannuzzi, F; Fabris, Fm; Fontana, P; Reati, R; Grillo, P; Aghemo, A; de Franchis, R; Primignani, M | |
| F-18-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients | 1-gen-2007 | Troost, Egc; Vogel, Wv; Merkx, Maw; Slootweg, Pj; Marres, Ham; Peeters, Wjm; Bussink, J; van der Kogel, Aj; Oyen, W; Kaanders, Jham | |
| Determining the optimal tumor volume cut-off for prediction of biochemical recurrence after radical prostatectomy in high-risk prostate cancer patients | 1-gen-2012 | Castiglione, F; Albersen, M; Russo, A; Abdollah, F; Passoni, N; Gallina, A; Suardi, N; Cestari, A; Guazzoni, G; Rigatti, P; Briganti, A | |
| Radionuclide therapy of cancer with radiolabeled antibodies | 1-gen-2007 | Boerman, Oc; Koppe, Mj; Postema, Ej; Corstens, Fh; Oyen, W | |
| Gender differences in Parkinson's disease | 1-gen-2007 | Haaxma, Ca; Bloem, Br; Borm, Gf; Oyen, W; Leenders, Kl; Eshuis, S; Booij, J; Dluzen, De; Horstink, Mw | |
| Development and application of peptide-based radiopharmaccuticals | 1-gen-2007 | Dijkgraaf, I; Boerman, Oc; Oyen, W; Corstens, Fhm; Gotthardt, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista27939
Data di pubblicazione
- In corso di stampa14
- 2020 - 20269661
- 2010 - 201911848
- 2000 - 20094579
- 1990 - 19991485
- 1980 - 1989329
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE372
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...267
- ANNALS OF ONCOLOGY244
- CANCERS232
- PLOS ONE223
- THE JOURNAL OF NUCLEAR MEDICINE222
- JOURNAL OF CLINICAL MEDICINE215
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY197
- ALLERGY180
Keyword
- Humans2166
- Female1035
- Male996
- Middle Aged767
- Aged669
- Adult559
- COVID-19442
- Treatment Outcome373
- Animals329
- Retrospective Studies264
Lingua
- eng19991
- ita459
- spa14
- fre11
- ger8
- enm4
- por2
- chi1
Accesso al fulltext
- no fulltext25686
- reserved1362
- open891